Slides
Page 1
FAETH THERAPEUTICS COMPANY OVERVIEW Break through the PAM barrier . Oral inhibition of the PI3K / AKT / mTOR pathway , one of the most frequently altered pathways in cancer . SEPTEMBER 2026 © 2026 Faeth Therapeutics . faeth
FAETH THERAPEUTICS COMPANY OVERVIEW Break through the PAM barrier . Oral inhibition of the PI3K / AKT / mTOR pathway , one of the most frequently altered pathways in cancer . SEPTEMBER 2026 © 2026 Faeth Therapeutics . faeth
Your watchlist and earnings event details are available after you sign in.